Wolf Myles
Insider CIK 1808317 · AKBA Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| AKBA Akebia Therapeutics, Inc. | A Award deriv | 2026-06-17 | 2026-06-22 | 53,600 | — | $0 | 53,600 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award | 2026-06-17 | 2026-06-22 | 35,700 | — | $0 | 169,081 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award deriv | 2025-06-10 | 2025-06-11 | 53,600 | — | $0 | 53,600 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award | 2025-06-10 | 2025-06-11 | 35,700 | — | $0 | 133,381 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award deriv | 2024-06-06 | 2024-06-10 | 45,000 | — | $0 | 45,000 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award | 2024-06-06 | 2024-06-10 | 30,000 | — | $0 | 97,681 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award deriv | 2023-06-06 | 2023-06-08 | 45,000 | — | $0 | 45,000 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award | 2023-06-06 | 2023-06-08 | 30,000 | — | $0 | 67,681 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award deriv | 2022-06-08 | 2022-06-09 | 20,100 | — | $0 | 20,100 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award | 2022-06-08 | 2022-06-09 | 13,700 | — | $0 | 37,681 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award deriv | 2021-06-02 | 2021-06-03 | 20,100 | — | $0 | 20,100 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award | 2021-06-02 | 2021-06-03 | 13,700 | — | $0 | 23,981 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award deriv | 2020-04-06 | 2020-04-07 | 80,200 | — | $0 | 80,200 | SEC↗ |